Authors
Omar Hamdan, Sarah Otoom, Noureddin Abdaljaleel, Ahmad Sandouka, Hams Alsakarneh, Nour Al-Ruwaidan, Sara Qreini, Aktham El Hadid, Hala Rabi, Francisco Arias
Published in
The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology. Volume 78. Issue 1. Nov 09, 2026. Epub Nov 09, 2026.
Abstract
Idiopathic Aortitis (IA) is defined as inflammation of the aortic wall, in the absence of a systemic disease or an infection. Most cases are found incidentally during repair of thoracic aortic aneurysms. Given the rarity of the disease, data on IA diagnosis and treatment are limited and derived mainly from small observational studies. This study aims to comprehensive and up-to-date synthesis of the available evidence on IA.
Literature search of the PubMed, Scopus, and Web of Science databases was performed in late September 2025. Data regarding patients' medical history, presentations, complications, diagnostic investigations, management and outcomes were obtained.
A total of 58 studies were included, comprising data from 79 patients with idiopathic aortitis. The mean age was 46 ± 20 years, with a slight male predominance of 53%. Weight loss was the most frequently reported symptom (58%). Regarding management, 44% underwent exclusive surgical treatment, 31% received mixed therapy, and 25% were managed medically. Corticosteroids were utilized in 51% of cases. The overall mortality rate was 20%. Significant predictors of mortality included a younger age at presentation (18 vs. 48 years, P < 0.001) and descending aorta involvement (P = 0.005). Conversely, corticosteroid administration (P = 0.002) and clinical surveillance (P < 0.001) were significantly associated with survival.
This meta-analysis highlights idiopathic aortitis as a severe condition with significant mortality whereas the administration of corticosteroids and clinical surveillance are strongly associated with survival, our findings emphasize the need for standardized, evidence-based management protocols and prospective multicenter studies to optimize patient outcomes.
PMID:
43002292
Bibliographic data and abstract were imported from PubMed on 10 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 15
- Comments 0